Your session is about to expire
Selective vs Nonselective Beta Blockers
Introduction
For patients dealing with hypertension, heart failure or certain arrhythmias, beta blockers are a common class of medication that can assist in managing symptoms. Selective and nonselective beta blockers are two types within this category; each has its unique impact on the body's systems but both aim to reduce high blood pressure.
Selective beta-blockers primarily target the heart's receptors (beta-1), thereby reducing the heart rate and lowering blood pressure. They have less effect on lung function making them safer for individuals with respiratory issues like asthma or chronic obstructive pulmonary disease (COPD). Metoprolol is an example of a selective beta blocker.
Nonselective beta blockers, on the other hand, influence both the heart's receptors (beta-1) and those found in other parts of your body like lungs and kidneys (beta-2). While they also lower blood pressure and slow down your heartbeat, their wider range action might cause more side effects such as narrowing airways or impeding glycogen breakdown. Propranolol falls into this category.
Selective vs Nonselective Beta Blockers Side By Side
| Attribute | Atenolol | Propranolol |
|---|---|---|
| Brand Name | Atenolol | Propranolol |
| Contraindications | Severe bradycardia, untreated heart failure, severe peripheral artery disease, certain asthma medications | Asthma, COPD, severe bradycardia, untreated heart failure, severe peripheral artery disease |
| Cost | Brand: ~$220 for 60 tablets (50 mg), Generic: $0.10 to $0.20 per day | Brand: ~$100 for 60 tablets (40 mg), Generic: $0.05 to $1.00 per day |
| Generic Name | Atenolol | Propranolol |
| Most Serious Side Effect | Worsening asthma symptoms, severe allergic reactions, unusual heartbeats, low sodium levels, nervous system issues | Severe allergic reactions, mood or mental state changes, significant weight gain, difficulty breathing, slow or irregular heart rate |
| Severe Drug Interactions | Not specified in the article, but typically includes other blood pressure medications, certain asthma medications, and drugs that can lower heart rate | Not specified in the article, but typically includes other blood pressure medications, drugs affecting heart rhythm, and asthma medications |
| Typical Dose | 50-100 mg/day for hypertension, up to 200 mg/day for heart failure or angina | 5-40 mg/day initially, up to 640 mg/day in divided doses for certain conditions |
What is Selective?
Selective beta blockers, like metoprolol and atenolol, were a significant achievement over the first class of beta-blockers known as nonselective beta blockers. Selective beta blockers were created to perform more specifically by predominantly blocking the β1 receptors located mainly in the heart. This selectivity is believed to reduce side effects related to unwanted β2 blockade in other areas of the body such as lungs, which can lead to bronchoconstriction. They are prescribed for conditions including hypertension, angina pectoris and heart failure.
Nonselective beta blockers like propranolol and nadolol, on the other hand, block both β1 and β2 receptors. The blocking of β2 receptors may cause some additional side effects such as shortness of breath due its effect on airway constriction. However, they are still effective choices for certain medical conditions that might benefit from broader receptor blockade including migraines or portal hypertension.
What conditions is Selective approved to treat?
Selective beta blockers are used for the treatment of several cardiovascular conditions, including:
- Hypertension (high blood pressure)
- Angina pectoris (chest pain usually caused by reduced blood flow to the heart)
- Heart failure
Nonselective beta blockers, on the other hand, have a wider range of applications beyond cardiovascular disorders like:
- Prevention of migraine
- Management of anxiety
- Treatment for glaucoma
How does Selective help with these illnesses?
Selective beta blockers help to manage conditions like hypertension and heart disease by specifically targeting the beta-1 adrenergic receptors found primarily in cardiac tissue. They work by blocking these receptors, thereby reducing the effect of adrenaline and noradrenaline on the heart. This results in a decrease in heart rate, blood pressure, and strain on your heart.
Nonselective beta blockers, on the other hand, block both beta-1 and beta-2 adrenergic receptors. The latter are found not only in the heart but also in smooth muscles of blood vessels as well as bronchial tubes. While nonselective blockers can be effective at managing cardiovascular conditions like their selective counterparts, they may cause more side effects such as constriction of airways or cold hands/feet due to reduced circulation.
Both types of medications have important roles depending upon individual patient scenarios; however one needs to consider potential side effects while choosing between them.
What is Nonselective Beta Blockers?
Nonselective beta blockers, such as propranolol and nadolol, are medications that block the action of both β1 and β2 adrenergic receptors. By inhibiting these receptors, they reduce the heart rate, decrease blood pressure and help to alleviate symptoms of angina or irregular heart rhythms. They were first introduced in the 1960s as a revolutionary treatment for angina pectoris. Unlike selective beta blockers which only inhibit β1 receptors found mainly in cardiac tissue, nonselective ones also affect β2 receptors located primarily in bronchial and vascular smooth muscle tissues. This broad spectrum activity means their side-effect profile is slightly different from that of selective beta blockers - they may cause more respiratory side effects like shortness of breath or exacerbation of asthma symptoms. However, their widespread action can be beneficial for treating conditions like hypertension and arrhythmia especially in patients who do not respond well to selective beta blockers.
What conditions is Nonselective Beta Blockers approved to treat?
Nonselective Beta Blockers are approved for the treatment of a range of conditions, including:
- Hypertension (high blood pressure)
- Angina pectoris (chest pain due to heart disease)
- Cardiac arrhythmias (irregular heartbeats)
- Heart attack prevention and aftercare These drugs work by blocking beta receptors in various parts of the body, not just the heart. This broad action can be more effective for certain conditions but may also lead to additional side effects compared to selective beta blockers.
How does Nonselective Beta Blockers help with these illnesses?
Norepinephrine, along with adrenaline, is also a driving factor in the body's "fight or flight" response. Nonselective beta blockers work by inhibiting both beta-1 and beta-2 receptors, thus reducing the effect of norepinephrine and adrenaline. This can result in lowered blood pressure, reduced heart rate, and decreased anxiety symptoms. By blocking these neurotransmitters' effects on the heart (beta-1) and on smooth muscle/bronchial tissue (beta-2), nonselective beta blockers help manage conditions such as hypertension, angina pectoris, irregular heart rhythms and even migraines. However, they may not be suitable for patients with certain respiratory conditions like asthma due to their impact on bronchial tissues unlike selective Beta Blockers which act primarily on the cardiovascular system.
How effective are both Selective and Nonselective Beta Blockers?
Both selective and nonselective beta blockers are established medications used to manage conditions such as hypertension, heart failure, angina pectoris, and arrhythmias. The primary difference between the two lies in their specificity of action; while both types block adrenaline from binding to beta receptors on nerves, selective (also known as cardioselective) beta blockers primarily affect those found in the heart (beta-1 receptors) whereas nonselective ones also impact those located in other parts of the body including lungs and blood vessels (beta-2 receptors).
A 2007 meta-analysis comparing cardioselective to non-cardioselective beta-blockers showed that there was little difference between them with regards to overall mortality or total coronary events for patients with chronic obstructive pulmonary disease. However, people receiving non-selective beta-blockers experienced more respiratory side effects.
A large-scale review published by Cochrane Database System Review in 2017 demonstrated that both types of beta blockers effectively reduce blood pressure when given alone or as part of combination therapy. Selectivity did not seem to have an impact on outcome measures like stroke or death from cardiovascular causes.
Nonetheless, due to their broader spectrum of action potentially leading to a higher risk for adverse reactions such as bronchospasm particularly among asthma patients or peripheral vasoconstriction manifesting as cold hands and feet among others, non-selective beta blockers may be considered only after first-line treatments fail. On the other hand, because they specifically target cardiac tissue without significantly affecting lung function at therapeutic doses thus offering a slightly better safety profile than their counterparts especially for individuals with co-existing lung diseases like asthma and COPD who require this class of medicines for their cardiac issues.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Selective typically prescribed?
Dosages of selective beta blockers, such as metoprolol, vary depending on the condition being treated. For high blood pressure, dosages typically range from 50-100 mg/day. However, for heart failure or angina relief, dosages can increase to up to 200 mg/day in divided doses. Nonselective beta blockers like propranolol are used at lower doses for anxiety (starting around 10-20mg twice daily) and higher doses for conditions like arrhythmia or migraines (up to 320mg per day). As with any medication regimen, dosage adjustments may be made based on individual patient response and tolerability under medical supervision. The maximum dose should never exceed what is recommended by healthcare professionals.
At what dose is Nonselective Beta Blockers typically prescribed?
Nonselective beta blockers treatment typically begins with a dosage of 5-40 mg/day, depending on the specific medication and illness being treated. The dose can then be increased as prescribed by your doctor, often divided into two doses spaced approximately 12 hours apart. For certain medications and conditions, the maximum daily dose can range up to 640 mg/day divided into two or three doses spread evenly throughout the day. This high dosage may be considered if there is no response to lower dosages after an adequate trial period, but always under close medical supervision due to potential side effects. As with any drug regimen, it's crucial that patients follow their healthcare provider’s instructions for nonselective beta blockers usage meticulously.
What are the most common side effects for Selective?
The side effects of selective and nonselective beta blockers can vary:
- Both types may cause fatigue or weakness, but it's potentially more pronounced with non-selective beta blockers.
- Non-selective beta blockers might lead to a feeling of coldness in the extremities.
- Insomnia and vivid dreams are possible side effects of both, though possibly more common with nonselective beta blockers.
- Selective ones often have fewer gastrointestinal issues like nausea or diarrhea than their counterparts.
- Nonselective variants may induce dry mouth more frequently.
- Erectile dysfunction is a potential concern for men taking any type of beta blocker.
- The development of rashes could be noted in rare instances for both categories.
Remember that the extent to which these symptoms present themselves can differ greatly between individuals due to factors such as age, overall health status, and additional medication usage.
Always consult your healthcare provider when you notice unusual changes after starting a new medication.
Are there any potential serious side effects for Selective?
Selective and nonselective beta blockers are generally safe, but they can sometimes cause side effects. Be aware of the following:
- Problems with breathing or worsening asthma symptoms. Selective beta-blockers are less likely to affect airways function, whereas non-selective ones might exacerbate asthmatic conditions.
- Allergic reactions: hives, difficulty in breathing, swelling around your face or throat
- Vision problems: blurred vision may occur as a side effect; if it persists or worsens tell your doctor promptly.
- Unusual heartbeats: slow or uneven heartbeats could be experienced after taking these medications; immediate medical help is needed if you feel like fainting.
- Lower sodium levels - which can lead to headaches, confusion, slurred speech, severe weakness and unsteady feelings. If noticed any such signs do not hesitate to consult with healthcare provider.
- Nervous system issues: In rare cases you may experience stiffness in muscles along with high fever and sweating followed by fast/uneven heartbeat & tremors leading towards fainting feeling.
In addition remember that sudden withdrawal from beta blockers can precipitate life-threatening tachycardia (fast heart rate), hypertension (high blood pressure) and ischemic events so always follow physician's advice while discontinuing them.
What are the most common side effects for Nonselective Beta Blockers?
Nonselective Beta Blockers can come with the following potential side effects:
- Slower heart rate
- Fatigue or feeling weak
- Cold hands and feet
- Diarrhea or constipation
- Upset stomach, nausea, vomiting
- Sleep disturbances including nightmares and insomnia
- Shortness of breath particularly in those with pre-existing lung conditions
- Dizziness or lightheadedness especially upon standing up quickly due to lowered blood pressure
- Depression or confusion may occur in some cases.
It's important to note that not everyone who takes nonselective beta blockers will experience these side effects but it's crucial to monitor your health closely while on this medication.
Are there any potential serious side effects for Nonselective Beta Blockers?
Nonselective beta blockers have a wide range of effects on the body and can cause various side effects including:
- Signs of a severe allergic reaction, such as hives, difficulty breathing, or swelling in your face or throat
- Changes in mood or mental state, such as confusion, depression or hallucinations
- Cold hands and feet (from reduced blood flow)
- Significant weight gain due to fluid retention
- Difficulty sleeping or vivid dreams
- Shortness of breath with slight exertion; even at rest it might be difficult to breathe
- Slow heart rate that could be irregular.
If you notice any of these symptoms while taking nonselective beta blockers, it is important to contact your healthcare provider immediately for medical advice. Remember that these medications should never be discontinued abruptly without consulting with your doctor.
Contraindications for Selective and Nonselective Beta Blockers?
Both selective and nonselective beta blockers, like most heart medications, may cause side effects such as fatigue, cold hands or feet, weight gain or decreased heart rate. If you experience severe dizziness, fainting or difficulty breathing after starting these medications please seek immediate medical attention.
Neither selective nor nonselective beta blockers should be taken if you are taking certain asthma medication (beta-2 agonists), have a slow heartbeat (bradycardia), severe peripheral artery disease or untreated heart failure. Always inform your healthcare provider about any other drugs you are on; abrupt withdrawal from beta-blockers can exacerbate symptoms of angina and may increase the risk of a sudden cardiac event.
In particular with non-selective beta blockers they also block the receptors in the lungs which can lead to narrowing of the airways making it harder for those with respiratory issues such as COPD and Asthma to breathe effectively.
How much do Selective and Nonselective Beta Blockers cost?
For the brand name versions of these drugs:
- The price of 60 tablets of atenolol (a selective beta-blocker, 50 mg) averages around $220, which works out to about $3.70/day if you're taking a typical dose.
- The price for propranolol (a nonselective beta-blocker), is approximately $100 for 60 tablets (40 mg), working out to roughly $1.66 per day.
Thus, if your prescribed dosage falls within the typical range for either drug, then brand-name propranolol is less expensive on a per-day treatment basis than atenolol. However, cost should not be the primary consideration in determining which type of beta blocker is right for you.
As for generic versions:
- Generic atenolol comes in packages ranging from 30 to 90 tablets with costs as low as $0.10 to $0.20 per day depending on your daily dosage.
- Generic propranolol can also be bought in packs starting from 15 up to hundreds of pills varying between dosages and brands but starts from approximately as low as $0.05/day and does not exceed about $1/day.
Again, while generics are typically less expensive than their branded counterparts, it's crucial that affordability isn't your sole decision-making factor when choosing medications; efficacy and suitability should always come first.
Popularity of Selective and Nonselective Beta Blockers
Selective beta blockers, such as metoprolol and atenolol, are medications that primarily block the beta-1 receptors located in the heart. This makes them particularly useful for conditions like hypertension, angina, and after a heart attack. In 2020, about 20 million people in the US were prescribed selective beta blockers. They accounted for approximately 30% of all prescriptions for high blood pressure medication.
Nonselective beta blockers like propranolol not only block the beta-1 receptors but also affect the beta-2 receptors found in other parts of body including lungs and blood vessels. They've been prescribed to nearly 5 million Americans last year making up around 7% of total prescriptions for blood pressure medication. While they're less commonly used due to more potential side effects compared to their selective counterparts, nonselective versions have broader utility including preventing migraines or managing symptoms of anxiety.
Conclusion
Both selective and nonselective beta blockers have long-standing records of usage in patients with cardiovascular diseases, and are backed by numerous clinical studies indicating that they can reduce morbidity and mortality. In some cases, the drugs may be combined with other classes of medications depending on the specific cardiac condition. Due to their different mechanisms of action, with selective beta blockers primarily affecting beta-1 receptors (located mainly in heart tissues), while non-selective ones block both beta-1 and beta-2 receptors (found also in lungs, arteries, uterus among others), they tend to be prescribed under different circumstances.
Selective beta blockers like metoprolol or atenolol are often considered first-line treatment for hypertension or angina due to a lower risk of side-effects related to airway constriction or peripheral vasoconstriction seen with non-selective agents such as propranolol.
Both types are available generically which represents significant cost savings especially for patients who must pay out-of-pocket. Like all medication treatments an adjustment period is usually needed before full effects become noticeable.
The side effect profile differs between the two categories: Nonselective blockers may cause more side effects including bronchoconstriction leading to breathing difficulties especially in asthma patients and Raynaud's phenomenon — cold hands/feet due to decreased blood flow; whereas selective ones may have less impact on lung function but still can slow heartbeat excessively or worsen symptoms of peripheral arterial disease. For both types, patients should closely monitor their conditions during therapy initiation or dosage change and consult healthcare providers promptly if any concerning signs occur.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Wood, A. J. J. (1984, October). Pharmacologic differences between beta blockers. American Heart Journal. Elsevier BV.http://doi.org/10.1016/0002-8703(84)90583-0
- Manrique, C., Giles, T. D., Ferdinand, K. C., & Sowers, J. R. (2009, June 29). Realities of Newer β‐Blockers for the Management of Hypertension. The Journal of Clinical Hypertension. Wiley.http://doi.org/10.1111/j.1751-7176.2009.00140.x
- Wong, T.-S., Li, G., Li, S., Gao, W., Chen, G., Gan, S., … Du, Y. (2023, May 3). G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders. Signal Transduction and Targeted Therapy. Springer Science and Business Media LLC.http://doi.org/10.1038/s41392-023-01427-2
- Lewis, R. V., Jackson, P. R., & Ramsay, L. E. (1985). Side-effects of ?-blockers assessed using visual analogue scales. European Journal of Clinical Pharmacology. Springer Science and Business Media LLC.http://doi.org/10.1007/bf00543718
- Dahlöf, C., & Dimenäs, E. (1990, April). Side Effects of β-Blocker Treatments as Related to the Central Nervous System. The American Journal of the Medical Sciences. Elsevier BV.http://doi.org/10.1097/00000441-199004000-00004
- Brogden, R. N., Heel, R. C., Speight, T. M., & Avery, G. S. (1977, November). Metoprolol. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-197714050-00001
- Shanks, R. G. (1991, March). Clinical pharmacology of vasodilatory β-blocking drugs. American Heart Journal. Elsevier BV.http://doi.org/10.1016/0002-8703(91)90612-l
- Kendall, M. J. (1987, May). Impact of beta1 selectivity and intrinsic sympathomimetic activity on potential unwanted noncardiovascular effects of beta blockers. The American Journal of Cardiology. Elsevier BV.http://doi.org/10.1016/0002-9149(87)90041-5
- Hong, J.-S., & Kang, H.-C. (2014, December). Regional Differences in Treatment Frequency and Case-Fatality Rates in Korean Patients With Acute Myocardial Infarction Using the Korea National Health Insurance Claims Database. Medicine. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1097/md.0000000000000287
- Heel, R. C., Brogden, R. N., Pakes, G. E., Speight, T. M., & Avery, G. S. (1980, July). Nadolol. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-198020010-00001
- Jabbour, A., Macdonald, P. S., Keogh, A. M., Kotlyar, E., Mellemkjaer, S., Coleman, C. F., … Hayward, C. S. (2010, April). Differences Between Beta-Blockers in Patients With Chronic Heart Failure and Chronic Obstructive Pulmonary Disease. Journal of the American College of Cardiology. Elsevier BV.http://doi.org/10.1016/j.jacc.2010.01.024
- Anderson, S. C., Jones, W. N., & Evanko, T. M. (2003, December 1). Dosage of β-adrenergic blockers after myocardial infarction. American Journal of Health-System Pharmacy. Oxford University Press (OUP).http://doi.org/10.1093/ajhp/60.23.2471
- Lewis, R. V., & McDevitt, D. G. (1986, October). Adverse Reactions and Interactions with β-Adrenoceptor Blocking Drugs. Medical Toxicology. Springer Science and Business Media LLC.http://doi.org/10.1007/bf03259848
- Frishman, W. H. (1988, March). Beta-adrenergic receptor blockers. Adverse effects and drug interactions. Hypertension. Ovid Technologies (Wolters Kluwer Health).http://doi.org/10.1161/01.hyp.11.3_pt_2.ii21